{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:34:06Z","timestamp":1761060846993},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00345-019-02897-2","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T12:03:07Z","timestamp":1565092987000},"page":"1243-1252","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management"],"prefix":"10.1007","volume":"38","author":[{"given":"Aryeh","family":"Pelcovits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catrina","family":"Mueller-Leonhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Mega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Golijanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Gershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"issue":"1","key":"2897_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, Babjuk M, Comperat E et al (2018) European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111\u2013122","journal-title":"Eur Urol"},{"issue":"10","key":"2897_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.6004\/jnccn.2017.0156","volume":"15","author":"PE Spiess","year":"2017","unstructured":"Spiess PE, Agarwal N, Bangs R et al (2017) Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw JNCCN 15(10):1240\u20131267","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"3","key":"2897_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","volume":"66","author":"JJ Leow","year":"2014","unstructured":"Leow JJ, Martin-Doyle W, Fay AP, Choueiri TK, Chang SL, Bellmunt J (2014) A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol 66(3):529\u2013541","journal-title":"Eur Urol"},{"issue":"6","key":"2897_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115(6):1224\u20131233","journal-title":"Cancer"},{"issue":"13","key":"2897_CR5","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1002\/cncr.25050","volume":"116","author":"SF Matin","year":"2010","unstructured":"Matin SF, Margulis V, Kamat A et al (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116(13):3127\u20133134","journal-title":"Cancer"},{"issue":"12","key":"2897_CR6","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.28655","volume":"120","author":"S Porten","year":"2014","unstructured":"Porten S, Siefker-Radtke AO, Xiao L et al (2014) Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer 120(12):1794\u20131799","journal-title":"Cancer"},{"issue":"8","key":"2897_CR7","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","volume":"35","author":"T Seisen","year":"2017","unstructured":"Seisen T, Krasnow RE, Bellmunt J et al (2017) Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma. J Clin Oncol 35(8):852\u2013860","journal-title":"J Clin Oncol"},{"issue":"6_suppl","key":"2897_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1200\/JCO.2018.36.6_suppl.407","volume":"36","author":"AJ Birtle","year":"2018","unstructured":"Birtle AJ, Chester JD, Jones RJ et al (2018) Results of POUT: a phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC). J Clin Oncol 36(6_suppl):407","journal-title":"J Clin Oncol"},{"issue":"1","key":"2897_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bju.12801","volume":"116","author":"I Lucca","year":"2015","unstructured":"Lucca I, Kassouf W, Kapoor A et al (2015) The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study. BJU Int 116(1):72\u201378","journal-title":"BJU Int"},{"issue":"2","key":"2897_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2016.12.027","volume":"72","author":"B Gershman","year":"2017","unstructured":"Gershman B, Moreira DM, Thompson RH et al (2017) Renal cell carcinoma with isolated lymph node involvement: long-term natural history and predictors of oncologic outcomes following surgical resection. Eur Urol 72(2):300\u2013306","journal-title":"Eur Urol"},{"issue":"6","key":"2897_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/bju.12814","volume":"114","author":"RJ Karmali","year":"2014","unstructured":"Karmali RJ, Suami H, Wood CG, Karam JA (2014) Lymphatic drainage in renal cell carcinoma: back to the basics. BJU Int 114(6):806\u2013817","journal-title":"BJU Int"},{"issue":"1","key":"2897_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1464-410X.2003.04017.x","volume":"91","author":"C Terrone","year":"2003","unstructured":"Terrone C, Guercio S, De Luca S et al (2003) The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91(1):37\u201340","journal-title":"BJU Int"},{"issue":"4","key":"2897_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","volume":"58","author":"MG Kaag","year":"2010","unstructured":"Kaag MG, O\u2019Malley RL, O\u2019Malley P et al (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58(4):581\u2013587","journal-title":"Eur Urol"},{"issue":"1","key":"2897_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.urology.2004.02.039","volume":"64","author":"Y Shirasaki","year":"2004","unstructured":"Shirasaki Y, Tsushima T, Saika T, Nasu Y, Kumon H (2004) Kidney function after nephrectomy for renal cell carcinoma. Urology 64(1):43\u201347 (discussion 48)","journal-title":"Urology"},{"issue":"8","key":"2897_CR15","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/j.1464-410X.2011.10075.x","volume":"108","author":"RF Youssef","year":"2011","unstructured":"Youssef RF, Shariat SF, Lotan Y et al (2011) Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int 108(8):1286\u20131291","journal-title":"BJU Int"},{"issue":"6","key":"2897_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.urolonc.2016.11.018","volume":"35","author":"A Cohen","year":"2017","unstructured":"Cohen A, Kuchta K, Park S (2017) Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma. Urol Oncol 35(6):322\u2013327","journal-title":"Urol Oncol"},{"issue":"5","key":"2897_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.urolonc.2016.11.017","volume":"35","author":"GE Gin","year":"2017","unstructured":"Gin GE, Ruel NH, Kardos SV et al (2017) Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma. Urol Oncol 35(5):192\u2013200","journal-title":"Urol Oncol"},{"issue":"7","key":"2897_CR18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00345-016-1972-6","volume":"35","author":"DM Golombos","year":"2017","unstructured":"Golombos DM, O\u2019Malley P, Lewicki P et al (2017) The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy. World J Urol 35(7):1063\u20131071","journal-title":"World J Urol"},{"issue":"6","key":"2897_CR19","doi-asserted-by":"publisher","first-page":"308.e319","DOI":"10.1016\/j.urolonc.2018.03.008","volume":"36","author":"A Klapheke","year":"2018","unstructured":"Klapheke A, Yap SA, Pan K, Cress RD (2018) Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer. Urol Oncol 36(6):308.e319\u2013308.e325","journal-title":"Urol Oncol"},{"issue":"5","key":"2897_CR20","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.juro.2016.05.082","volume":"196","author":"J Lara","year":"2016","unstructured":"Lara J, Brunson A, Keegan TH et al (2016) Determinants of survival for adolescents and young adults with urothelial bladder cancer: results from the california cancer registry. J Urol 196(5):1378\u20131382","journal-title":"J Urol"},{"issue":"16","key":"2897_CR21","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1002\/cncr.31587","volume":"124","author":"AY Odisho","year":"2018","unstructured":"Odisho AY, Etzioni R, Gore JL (2018) Beyond classic risk adjustment: socioeconomic status and hospital performance in urologic oncology surgery. Cancer 124(16):3372\u20133380","journal-title":"Cancer"},{"issue":"2","key":"2897_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.juro.2015.07.091","volume":"195","author":"ND Smith","year":"2016","unstructured":"Smith ND, Prasad SM, Patel AR et al (2016) Bladder Cancer mortality in the United States: a geographic and temporal analysis of socioeconomic and environmental factors. J Urol 195(2):290\u2013296","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02897-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02897-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02897-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T23:12:06Z","timestamp":1596582726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02897-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2897"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02897-2","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Lifespan institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}